Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1555-2026

Artelon FlexBand Plus Ref: 41054 & 41057 Recall

Artelon FlexBand Plus Ref: 41054 & 41057

FDA recall Class II

Ongoing

FDA lists this Class II recall for Artelon FlexBand Plus Ref: 41054 & 41057. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1555-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Feb 6, 2026
FDA report date
Mar 18, 2026
Quantity in commerce
N/A
Distribution
See key details
FDA cause
Process control

What is being recalled?

Artelon FlexBand Plus Ref: 41054 & 41057

Affected model & UDI checker

Search the exact identifiers published for Z-1555-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
41054Artelon FlexBand Plus Ref: 41054 & 41057Check source noticeNot specified
41057Artelon FlexBand Plus Ref: 41054 & 41057Check source noticeNot specified
Not specifiedArtelon FlexBand Plus Ref: 41054 & 41057Check source notice00850003396064
Not specifiedArtelon FlexBand Plus Ref: 41054 & 41057Check source notice00850003396033
FDA code information

REF: 41054 -Lot: A10010201/GTIN: 00850003396064 REF: 41057 - Lot: A10010101/GTIN: 00850003396033

View the original FDA recall notice

Why was this product recalled?

Augmentation devices failed bacterial endotoxin testing.

What actions did INTERNATIONAL LIFE SCIENCES take?

On February 6, 2026, International Life Science ( subsidiary of Stryker) issued a Urgent: Medical Device Recall notification to affected consignees. International Life Science asked consignees to take the following actions: 1. Immediately check your internal inventory to locate the product, remove them from their point of use, and isolate/quarantine the unit(s) to prevent accidental use. 2. Review the product issue and risks as communicated and communicate the issue as appropriate in your organization. 3. Return the enclosed business reply form by email a. Response is required, even if you may not have any physical inventory on site anymore. 4. Upon receipt of the completed business reply form, Stryker will contact you to arrange for the return of your product(s). 5. Maintain awareness of this communication internally until required actions have been completed within your facility. 6. If you have further distributed the affected product, please notify the applicable parties. a. If possible, inform us if any of the subject devices have been distributed to other organizations, including contact details, so that we can inform the recipients appropriately. b. If you are a distributor, note that you are responsible for notifying your affected customers.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology
Z-1555-2026: Artelon FlexBand Plus Ref: 41054 & 41057 recall | MedtechLedger